SCHEMBL6524

SCHEMBL6524

[CH]C1CCCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10340141 1.00 ALDH1A1 (0.36)
SCHEMBL721796 1.00
SCHEMBL54025 1.00
SCHEMBL7359 0.95
SCHEMBL7914 0.80
SCHEMBL6740 0.80
SCHEMBL300448 0.75
SCHEMBL11028224 0.70
SCHEMBL7631481 0.67
SCHEMBL1660438 0.64 ALDH1A1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150284615-A1 LOW-VOC DIALKYL-FUNCTIONAL ALKOXYSILOXANES, PROCESSES AND USE THEREOF AS HYDROPHOBIZING IMPREGNATING AGENTS FOR MINERAL BUILDING MATERIALS EVONIK INDUSTRIES AG (DE) 2015-10-08 US claimed
EP-2927291-A1 Low VOC dialkyl-functional alkoxysiloxanes, method and their use as hydrophobizing impregnating agent for mineral building materials Evonik Degussa GmbH (DE) 2015-10-07 EP claimed
US-20070265278-A1 2-PHENYL-INDOLES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS AVENTIS PHARMACEUTICALS INC. (US) 2007-11-15 US claimed
EP-1844011-A1 2-PHENYL-INDOLES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS Aventis Pharmaceuticals Inc. (US) 2007-10-17 EP claimed
WO-2006081343-A1 2-PHENYL-INDOLES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS AVENTIS PHARMACEUTICALS INC. (US) 2006-08-03 WO claimed
US-4426389-A BACTERICIDES, ENZYME INHIBITORS BEECHAM GROUP LIMITED (GB) 1984-01-17 US claimed
CN-110769821-B Spiro indolines as IL-17 modulators UCB生物制药有限责任公司 2023-07-07 CN disclosed
EP-2414328-B1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO SA (CH) 2021-05-26 EP disclosed
US-10377692-B2 Photoresist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-08-13 US disclosed
EP-2250165-B1 TRIAZOLE OXADIAZOLES DERIVATIVES MERCK SERONO SA (CH) 2018-07-25 EP disclosed
EP-3219713-A1 INHIBITORS OF FLAVIVIRIDAE VIRUSES Gilead Sciences, Inc. (US) 2017-09-20 EP disclosed
EP-2193125-B1 OXADIAZOLE DERIVATIVES MERCK SERONO SA (CH) 2017-01-11 EP disclosed
US-9528036-B2 Low-voc dialkyl-functional alkoxysiloxanes, processes and use thereof as hydrophobizing impregnating agents for mineral building materials EVONIK DEGUSSA GMBH (DE) 2016-12-27 US disclosed
WO-1998027094-A1 ETHYLIDENE DERIVATIVES OF TRICYCLIC CARBAPENEMS LEK TOVARNA FARMACEVTSKIH IN KEMIC^¿NIH IZDELKOV, D.D. (SI) 1998-06-25 WO disclosed
US-4735959-A HYPOGLYCEMIC AGENTS DR. KARL THOMAE GMBH (DE) 1988-04-05 US disclosed
US-4549992-A Antihypertensive amides USV PHARMACEUTICAL CORP. (US) 1985-10-29 US disclosed
EP-0058779-B1 CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS MEDICINES Dr. Karl Thomae GmbH (DE) 1984-09-19 EP disclosed
US-4426389-A BACTERICIDES, ENZYME INHIBITORS BEECHAM GROUP LIMITED (GB) 1984-01-17 US disclosed
EP-0058779-A2 Carboxamides, their preparation and their use as medicines Dr. Karl Thomae GmbH (DE) 1982-09-01 EP disclosed
EP-0027324-A1 Derivatives of clavulanic acid, processes for their preparation and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1981-04-22 EP disclosed